ASO Visual Abstract: Optimizing the Indications for Conversion Surgery Based on an Analysis of 454 Consecutive Japanese Cases with Unresectable Pancreatic Cancer Who Received Modified FOLFIRINOX or Gemcitabine Plus Nab-paclitaxel: A Single-Center Retrospective Study
Sign Up to like & getrecommendations! Published in 2022 at "Annals of Surgical Oncology"
DOI: 10.1245/s10434-022-11741-8
Abstract: This a single-center retrospective study that investigated the optimal indication of resection in 454 consecutive unresectable pancreatic cancer with modified FFX or GNP chemotherapy. Four independent prognostic factors for favorable survival outcomes were identified: normal… read more here.
Keywords: unresectable pancreatic; center retrospective; retrospective study; single center ... See more keywords